The cerebral effects of ascent to high altitudes

Vardy, 2006, Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya, Aviat Space Environ Med, 77, 742 Wu, 2007, Who should not go high: chronic disease and work at altitude during construction of the Qinghai–Tibet railroad, High Alt Med Biol, 8, 88, 10.1089/ham.2007.1015 Wu, 2006, Ataxia: an early indicator in high altitude cerebral edema, High Alt Med Biol, 7, 275, 10.1089/ham.2006.7.275 Hackett, 2001, High-altitude illness, N Engl J Med, 345, 107, 10.1056/NEJM200107123450206 Basnyat, 2003, High-altitude illness, Lancet, 361, 1967, 10.1016/S0140-6736(03)13591-X West, 1996, T H Ravenhill and his contributions to mountain sickness, J Appl Physiol, 80, 715, 10.1152/jappl.1996.80.3.715 Ravenhill, 1913, Some experiences of mountain sickness in the Andes, Journal of Tropical Medicine and Hygiene, 16, 313 West, 2007, 40 Kramer, 1993, Cognitive function at high altitude, Hum Factors, 35, 329, 10.1177/001872089303500208 Nelson, 1982, Psychological testing at high altitudes, Aviat Space Environ Med, 53, 122 Berry, 1989, Isocapnic hypoxemia and neuropsychological functioning, J Clin Exp Neuropsychol, 11, 241, 10.1080/01688638908400886 Fowler, 1987, The threshold for hypoxia effects on perceptual-motor performance, Hum Factors, 29, 61, 10.1177/001872088702900106 2004, The International Classification of Headache Disorders, 2nd edn, Cephalalgia, 24, 9 Roach, 1993, Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system, 272 Sampson, 1983, Procedures for the measurement of acute mountain sickness, Aviat Space Environ Med, 54, 1063 Grissom, 1992, Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange, Ann Intern Med, 116, 461, 10.7326/0003-4819-116-6-461 Bradwell, 1992, Acetazolamide and high altitude diseases, Int J Sports Med, 13, S63, 10.1055/s-2007-1024597 Basnyat, 2003, Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial, High Alt Med Biol, 4, 45, 10.1089/152702903321488979 Bartsch, 2001, Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide, BMJ, 322, 48 Basnyat, 2006, Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial, High Alt Med Biol, 7, 17, 10.1089/ham.2006.7.17 Vuyk, 2006, Acetazolamide improves cerebral oxygenation during exercise at high altitude, High Alt Med Biol, 7, 290, 10.1089/ham.2006.7.290 Hackett, 1988, Dexamethasone for prevention and treatment of acute mountain sickness, Aviat Space Environ Med, 59, 950 Johnson, 1984, Prevention of acute mountain sickness by dexamethasone, N Engl J Med, 310, 683, 10.1056/NEJM198403153101103 Basu, 2002, Glucocorticoids as prophylaxis against acute mountain sickness, Clin Endocrinol, 57, 761, 10.1046/j.1365-2265.2002.01664.x Roncin, 1996, EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure, Aviat Space Environ Med, 67, 445 Gertsch, 2004, Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT), BMJ, 328, 797, 10.1136/bmj.38043.501690.7C Bailey, 2001, Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude, High Alt Med Biol, 2, 21, 10.1089/152702901750067882 Bartsch, 1991, Prevention of high-altitude pulmonary edema by nifedipine, N Engl J Med, 325, 1284, 10.1056/NEJM199110313251805 Oelz, 1989, Nifedipine for high altitude pulmonary oedema, Lancet, 2, 1241, 10.1016/S0140-6736(89)91851-5 Chan, 2005, Effect of sildenafil and acclimatization on cerebral oxygenation at altitude, Clin Sci, 109, 319, 10.1042/CS20050036 Maggiorini, 2006, Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial, Ann Intern Med, 145, 497, 10.7326/0003-4819-145-7-200610030-00007 Hackett, 2004, High altitude cerebral edema, High Alt Med Biol, 5, 136, 10.1089/1527029041352054 Hackett, 1976, The incidence, importance, and prophylaxis of acute mountain sickness, Lancet, 2, 1149, 10.1016/S0140-6736(76)91677-9 Basnyat, 2004, Neurological conditions at altitude that fall outside the usual definition of altitude sickness, High Alt Med Biol, 5, 171, 10.1089/1527029041352126 Imray, 2008, Intrapulmonary and intracardiac shunting with exercise at altitude, Wilderness Environ Med, 19, 199, 10.1580/07-WEME-BR-162.1 Clarke, 2006, Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia, Postgrad Med J, 82, 748, 10.1136/pgmj.2006.047662 Dickinson, 1983, Altitude-related deaths in seven trekkers in the Himalayas, Thorax, 38, 646, 10.1136/thx.38.9.646 Song, 1986, Cerebral thrombosis at altitude: its pathogenesis and the problems of prevention and treatment, Aviat Space Environ Med, 57, 71 Zhou, 1984, Transient ischemic attack in young people at high altitude, Qinghai Med J, 14, 44 Nair, 2008, A case of hereditary protein S deficiency presenting with cerebral sinus venous thrombosis and deep vein thrombosis at high altitude, Acta Haematol, 119, 158, 10.1159/000126200 Boulos, 1999, Superior sagittal sinus thrombosis occurring at high altitude associated with protein C deficiency, Acta Haematol, 102, 104, 10.1159/000040980 Baumgartner, 2007, Going high with preexisting neurological conditions, High Alt Med Biol, 8, 108, 10.1089/ham.2006.1070 Hackett, 2001, High altitude and common medical conditions, 839 Woods, 2008, High altitude arrhythmias, Cardiology, 111, 239, 10.1159/000127445 Nicholas, 1992, Is syncope related to moderate altitude exposure?, Jama, 268, 904, 10.1001/jama.1992.03490070086048 Firth, 2008, Mortality on Mount Everest, 1921–2006: descriptive study, BMJ, 337, 1430, 10.1136/bmj.a2654 Zrinzo, 2006, Commercial flight and patients with intracranial mass lesions: a caveat. Report of two cases, J Neurosurg, 105, 627, 10.3171/jns.2006.105.4.627 Mader, 2003, Going to high altitude with preexisting ocular conditions, High Alt Med Biol, 4, 419, 10.1089/152702903322616173 Jafarian, 2008, High-altitude sleep disturbance: results of the Groningen Sleep Quality Questionnaire survey, Sleep Med, 9, 446, 10.1016/j.sleep.2007.06.017 Burgess, 2004, Acute mountain sickness is associated with sleep desaturation at high altitude, Respirology, 9, 485, 10.1111/j.1440-1843.2004.00625.x Virues-Ortega, 2004, Neuropsychological functioning associated with high-altitude exposure, Neuropsychol Rev, 14, 197, 10.1007/s11065-004-8159-4 Burgess, 2006, Effect of simulated altitude during sleep on moderate-severity OSA, Respirology, 11, 62, 10.1111/j.1440-1843.2006.00785.x Luks, 2008, Which medications are safe and effective for improving sleep at high altitude?, High Alt Med Biol, 9, 195, 10.1089/ham.2008.1025 Pollard, 2001, Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001, High Alt Med Biol, 2, 389, 10.1089/15270290152608561 Yaron, 1998, The diagnosis of acute mountain sickness in preverbal children, Arch Pediatr Adolesc Med, 152, 683, 10.1001/archpedi.152.7.683 Theis, 1993, Acute mountain sickness in children at 2835 meters, Am J Dis Child, 147, 143 Yaron, 2003, Physiologic response to moderate altitude exposure among infants and young children, High Alt Med Biol, 4, 53, 10.1089/152702903321488988 Southard, 2007, Language used in Lake Louise Scoring System underestimates symptoms of acute mountain sickness in 4- to 11-year-old children, High Alt Med Biol, 8, 124, 10.1089/ham.2006.1014 Wu, 1998, Effects of acute moderate hypoxia on human performance of arithmetic, Space Med Med Eng, 11, 391 Pelamatti, 2003, Verbal free recall in high altitude: proper names vs common names, Cortex, 39, 97, 10.1016/S0010-9452(08)70077-7 Du, 1999, [Effects of acute mild and moderate hypoxia on human short memory], Space Med Med Eng, 12, 270 Bouquet, 1999, Psychomotor skills learning under chronic hypoxia, Neuroreport, 10, 3093, 10.1097/00001756-199909290-00040 Bolmont, 2001, Relationships of personality traits with performance in reaction time, psychomotor ability, and mental efficiency during a 31-day simulated climb of Mount Everest in a hypobaric chamber', Percept Mot Skills, 92, 1022, 10.2466/pms.2001.92.3c.1022 Wesensten, 1993, Effects of simulated high altitude exposure on long-latency event-related brain potentials and performance, Aviat Space Environ Med, 64, 30 Wilson, 2008, Changes in pupil dynamics at high altitude—an observational study using a handheld pupillometer, High Altitude Medicine and Biology, 9, 319, 10.1089/ham.2008.1026 Bolmont, 2000, Relationships between mood states and performances in reaction time, psychomotor ability, and mental efficiency during a 31-day gradual decompression in a hypobaric chamber from sea level to 8848 m equivalent altitude, Physiol Behav, 71, 469, 10.1016/S0031-9384(00)00362-0 Reite, 1975, Sleep physiology at high altitude, Electroencephalogr Clin Neurophysiol, 38, 463, 10.1016/0013-4694(75)90188-1 Forster, 1985, Effect of different ascent profiles on performance at 4,200 m elevation, Aviat Space Environ Med, 56, 758 Kobrick, 1971, Effects of extended hypoxia on visual performance and retinal vascular state, J Appl Physiol, 31, 357, 10.1152/jappl.1971.31.3.357 Stobdan, 2008, High altitude adaptation: genetic perspectives, High Alt Med Biol, 9, 140, 10.1089/ham.2007.1076 Nelson, 1990, Cognition and metacognition at extreme altitudes on Mount Everest, J Exp Psychol Gen, 119, 367, 10.1037/0096-3445.119.4.367 Regard, 1989, Persistent cognitive impairment in climbers after repeated exposure to extreme altitude, Neurology, 39, 210, 10.1212/WNL.39.2.210 Hornbein, 1989, The cost to the central nervous system of climbing to extremely high altitude, N Engl J Med, 321, 1714, 10.1056/NEJM198912213212505 West, 1984, Human physiology at extreme altitudes on Mount Everest, Science, 223, 784, 10.1126/science.6364351 Johnson, 2005, Ataxia at altitude measured on a wobble board, Wilderness Environ Med, 16, 42, 10.1580/1080-6032(2005)16[42:AAAMOA]2.0.CO;2 Fagenholz, 2007, New-onset anxiety disorders at high altitude, Wilderness Environ Med, 18, 312, 10.1580/07-WEME-BR-102R1.1 Windsor, 2008, Voices in the air, BMJ, 337, 1433, 10.1136/bmj.a2667 Anooshiravani, 1999, Brain magnetic resonance imaging (MRI) and neurological changes after a single high altitude climb, Med Sci Sports Exerc, 31, 969, 10.1097/00005768-199907000-00008 Paola, 2008, Reduced oxygen due to high-altitude exposure relates to atrophy in motor-function brain areas, Eur J Neurol, 15, 1050, 10.1111/j.1468-1331.2008.02243.x Garrido, 1995, New evidence from magnetic resonance imaging of brain changes after climbs at extreme altitude, Eur J Appl Physiol Occup Physiol, 70, 477, 10.1007/BF00634375 Garrido, 1993, Cortical atrophy and other brain magnetic resonance imaging (MRI) changes after extremely high-altitude climbs without oxygen, Int J Sports Med, 14, 232, 10.1055/s-2007-1021169 Grocott, 2008, Genetophysiology: using genetic strategies to explore hypoxic adaptation, High Alt Med Biol, 9, 123, 10.1089/ham.2008.1012 Suzuki, 2003, Genetic variation in hypoxia-inducible factor 1alpha and its possible association with high altitude adaptation in Sherpas, Med Hypotheses, 61, 385, 10.1016/S0306-9877(03)00178-6 Prior, 2003, Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption, Physiol Genomics, 15, 20, 10.1152/physiolgenomics.00061.2003 Woods, 2001, Angiotensin-converting enzyme and genetics at high altitude, High Alt Med Biol, 2, 201, 10.1089/152702901750265305 Woods, 2002, Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude, Am J Respir Crit Care Med, 166, 362, 10.1164/rccm.2103060 Droma, 2008, Adaptation to high altitude in Sherpas: association with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene, Wilderness Environ Med, 19, 22, 10.1580/06-WEME-OR-073.1 Koehle, 2006, No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m, High Alt Med Biol, 7, 281, 10.1089/ham.2006.7.281 Rupert, 2006, Evidence for a genetic basis for altitude-related illness, High Alt Med Biol, 7, 150, 10.1089/ham.2006.7.150 Dehnert, 2002, No association between high-altitude tolerance and the ACE I/D gene polymorphism, Med Sci Sports Exerc, 34, 1928, 10.1097/00005768-200212000-00011 Patel, 2003, Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia, Eur Respir J, 22, 755, 10.1183/09031936.03.00086402 Williams, 2000, The ACE gene and muscle performance, Nature, 403, 614, 10.1038/35001141 Bartsch, 1991, Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness, J Appl Physiol, 71, 136, 10.1152/jappl.1991.71.1.136 Rajput, 2006, Predominance of interaction among wild-type alleles of CYP11B2 in Himalayan natives associates with high-altitude adaptation, Biochem Biophys Res Commun, 348, 735, 10.1016/j.bbrc.2006.07.116 Beall, 2001, Pulmonary nitric oxide in mountain dwellers, Nature, 414, 411, 10.1038/35106641 Erzurum, 2007, Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans, Proc Natl Acad Sci U S A, 104, 17593, 10.1073/pnas.0707462104 Wilson, 2007, Impact of genetic factors on outcome from brain injury, Br J Anaesth, 99, 43, 10.1093/bja/aem142 Ross, 1985, The random nature of cerebral mountain sickness, Lancet, 1, 990, 10.1016/S0140-6736(85)91771-4 Roach, 2001, Frontiers of hypoxia research: acute mountain sickness, J Exp Biol, 204, 3161, 10.1242/jeb.204.18.3161 Gore, 2007, Non-hematological mechanisms of improved sea-level performance after hypoxic exposure, Med Sci Sports Exerc, 39, 1600, 10.1249/mss.0b013e3180de49d3 Wilson, 2008, Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition, Neurosurgery, 63, 970, 10.1227/01.NEU.0000327885.15132.CA Singh, 1969, Acute mountain sickness, N Engl J Med, 280, 175, 10.1056/NEJM196901232800402 Hartig, 1992, Cerebral spinal fluid pressure and cerebral blood velocity in acute mountain sickness, 260 Bartsch, 2004, Acute mountain sickness: controversies and advances, High Alt Med Biol, 5, 110, 10.1089/1527029041352108 Garrido, 2000, Hallucinatory experiences at high altitude, Neuropsychiatry Neuropsychol Behav Neurol, 13, 148 Wright, 1995, Intracranial pressure at high altitude and acute mountain sickness, Clin Sci, 89, 201, 10.1042/cs0890201 Sutherland, 2008, Optic nerve sheath diameter, intracranial pressure and acute mountain sickness on Mount Everest: a longitudinal cohort study, Br J Sports Med, 42, 183, 10.1136/bjsm.2007.045286 Fagenholz, 2007, Evidence for increased intracranial pressure in high altitude pulmonary edema, High Alt Med Biol, 8, 331, 10.1089/ham.2007.1019 Murkin, 2007, Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study, Anesth Analg, 104, 51, 10.1213/01.ane.0000246814.29362.f4 Henson, 1998, Accuracy of a cerebral oximeter in healthy volunteers under conditions of isocapnic hypoxia, Anesthesiology, 88, 58, 10.1097/00000542-199801000-00011 Rostrup, 2002, Cerebral hemodynamics measured with simultaneous PET and near-infrared spectroscopy in humans, Brain Res, 954, 183, 10.1016/S0006-8993(02)03246-8 Boushel, 2000, Regional blood flow during exercise in humans measured by near-infrared spectroscopy and indocyanine green, J Appl Physiol, 89, 1868, 10.1152/jappl.2000.89.5.1868 Imray, 1998, Near-infrared spectroscopy in the assessment of cerebral oxygenation at high altitude, Wilderness Environ Med, 9, 198, 10.1580/1080-6032(1998)009[0198:NISITA]2.3.CO;2 Hadolt, 2003, Non-invasive assessment of cerebral oxygenation during high altitude trekking in the Nepal Himalayas (2850–5600 m), Neurol Res, 25, 183, 10.1179/016164103101201175 Imray, 2003, Effects of breathing air containing 3% carbon dioxide, 35% oxygen or a mixture of 3% carbon dioxide/35% oxygen on cerebral and peripheral oxygenation at 150 m and 3459 m, Clin Sci, 104, 203, 10.1042/CS20020102 Imray, 2005, Effect of exercise on cerebral perfusion in humans at high altitude, J Appl Physiol, 99, 699, 10.1152/japplphysiol.00973.2004 Subudhi, 2007, Effects of acute hypoxia on cerebral and muscle oxygenation during incremental exercise, J Appl Physiol, 103, 177, 10.1152/japplphysiol.01460.2006 Moller, 2002, Unchanged cerebral blood flow and oxidative metabolism after acclimatization to high altitude, J Cereb Blood Flow Metab, 22, 118, 10.1097/00004647-200201000-00014 Kety, 1945, The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations, Am J Physiol, 143, 53, 10.1152/ajplegacy.1945.143.1.53 Hochachka, 1994, The brain at high altitude: hypometabolism as a defense against chronic hypoxia?, J Cereb Blood Flow Metab, 14, 671, 10.1038/jcbfm.1994.84 Hochachka, 2000, Evolution of human hypoxia tolerance physiology, Adv Exp Med Biol, 475, 25, 10.1007/0-306-46825-5_5 Curran-Everett, 1991, Intracranial pressures and O2 extraction in conscious sheep during 72 h of hypoxia, Am J Physiol, 261, H103 Severinghaus, 1966, Cerebral blood flow in man at high altitude. Role of cerebrospinal fluid pH in normalization of flow in chronic hypocapnia, Circ Res, 19, 274, 10.1161/01.RES.19.2.274 Wolff, 2000, Cerebral blood flow and oxygen delivery at high altitude, High Alt Med Biol, 1, 33, 10.1089/152702900320667 Jensen, 1990, Cerebral blood flow in acute mountain sickness, J Appl Physiol, 69, 430, 10.1152/jappl.1990.69.2.430 Jansen, 1999, Cerebral vasomotor reactivity at high altitude in humans, J Appl Physiol, 86, 681, 10.1152/jappl.1999.86.2.681 Baumgartner, 1999, Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study, J Appl Physiol, 86, 1578, 10.1152/jappl.1999.86.5.1578 Huang, 1987, Internal carotid and vertebral arterial flow velocity in men at high altitude, J Appl Physiol, 63, 395, 10.1152/jappl.1987.63.1.395 Reeves, 1985, Headache at high altitude is not related to internal carotid arterial blood velocity, J Appl Physiol, 59, 909, 10.1152/jappl.1985.59.3.909 Otis, 1989, Relationship of cerebral blood flow regulation to acute mountain sickness, J Ultrasound Med, 8, 143, 10.7863/jum.1989.8.3.143 Baumgartner, 1994, Enhanced cerebral blood flow in acute mountain sickness, Aviat Space Environ Med, 65, 726 Van Osta, 2005, Effects of high altitude exposure on cerebral hemodynamics in normal subjects, Stroke, 36, 557, 10.1161/01.STR.0000155735.85888.13 Subudhi, 2008, Cerebrovascular responses to incremental exercise during hypobaric hypoxia: effect of oxygenation on maximal performance, Am J Physiol Heart Circ Physiol, 294, H164, 10.1152/ajpheart.01104.2007 Koyama, 1988, The increased sympathoadrenal activity in patients with high altitude pulmonary edema is centrally mediated, Jpn J Med, 27, 10, 10.2169/internalmedicine1962.27.10 Houston, 1975, Cerebral form of high-altitude illness, Lancet, 2, 758, 10.1016/S0140-6736(75)90735-7 Hackett, 1998, High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology, JAMA, 280, 1920, 10.1001/jama.280.22.1920 Morocz, 2001, Volumetric quantification of brain swelling after hypobaric hypoxia exposure, Exp Neurol, 168, 96, 10.1006/exnr.2000.7596 Kallenberg, 2007, Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness, J Cereb Blood Flow Metab, 27, 1064, 10.1038/sj.jcbfm.9600404 Schoonman, 2008, Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3T magnetic resonance imaging study, J Cereb Blood Flow Metab, 28, 198, 10.1038/sj.jcbfm.9600513 Fischer, 2004, No evidence of cerebral oedema in severe acute mountain sickness, Cephalalgia, 24, 66, 10.1111/j.1468-2982.2004.00619.x Matsuzawa, 1992, Cerebral edema in acute mountain sickness, 300 Krasney, 1994, A neurogenic basis for acute altitude illness, Med Sci Sports Exerc, 26, 195, 10.1249/00005768-199402000-00010 James, 1988, Hyperbaric oxygenation, carbon monoxide, and cerebral edema, BMJ, 296, 500, 10.1136/bmj.296.6620.500-c Varnell, 1987, CT diagnosis of toxic brain injury in cyanide poisoning: considerations for forensic medicine, AJNR Am J Neuroradiol, 8, 1063 Mills, 1999, Differential susceptibility of brain areas to cyanide involves different modes of cell death, Toxicol Appl Pharmacol, 156, 6, 10.1006/taap.1999.8630 Kasamo, 1993, Chronological changes of MRI findings on striatal damage after acute cyanide intoxication: pathogenesis of the damage and its selectivity, and prevention for neurological sequelae: a case report, Eur Arch Psychiatry Clin Neurosci, 243, 71, 10.1007/BF02191567 Dickinson, 1983, Altitude-related deaths in seven trekkers in the Himalayas, Thorax, 38, 646, 10.1136/thx.38.9.646 Kallenberg, 2008, Microhemorrhages in nonfatal high-altitude cerebral edema, J Cereb Blood Flow Metab, 28, 1635, 10.1038/jcbfm.2008.55 Hackett, 1999, The cerebral etiology of high-altitude cerebral edema and acute mountain sickness, Wilderness Environ Med, 10, 97, 10.1580/1080-6032(1999)010[0097:TCEOHA]2.3.CO;2 Kim, 2004, Diagnosis and managements of cerebral veous and sinus thrombosis, Seminars in Cerebrovascular Diseases and Stroke, 4, 205, 10.1053/j.scds.2005.01.005 Tsai, 1995, MR staging of acute dural sinus thrombosis: correlation with venous pressure measurements and implications for treatment and prognosis, AJNR Am J Neuroradiol, 16, 1021 Kilic, 2008, Anatomy of cerebral veins and sinuses, Front Neurol Neurosci, 23, 4, 10.1159/000111256 Bert, 1878 Mosso, 1898 Jensen, 1996, Augmented hypoxic cerebral vasodilation in men during 5 days at 3810 m altitude, J Appl Physiol, 80, 1214, 10.1152/jappl.1996.80.4.1214 Brugniaux, 2007, Cerebrovascular responses to altitude, Respir Physiol Neurobiol, 158, 212, 10.1016/j.resp.2007.04.008 Ainslie, 2004, Ventilatory, cerebrovascular, and cardiovascular interactions in acute hypoxia: regulation by carbon dioxide, J Appl Physiol, 97, 149, 10.1152/japplphysiol.01385.2003 Harvey, 1988, Effect of carbon dioxide in acute mountain sickness: a rediscovery, Lancet, 2, 639, 10.1016/S0140-6736(88)90465-5 Imray, 2001, Carbon dioxide contributes to the beneficial effect of pressurization in a portable hyperbaric chamber at high altitude, Clin Sci, 100, 151, 10.1042/CS20000058 Maher, 1975, Acute mountain sickness: increased severity in eucapnic hypoxia, Aviat Space Environ Med, 46, 826 Winn, 1981, Brain adenosine concentration during hypoxia in rats, Am J Physiol, 241, H235 Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels, Physiol Rev, 78, 53, 10.1152/physrev.1998.78.1.53 Sanders, 2000, The role of nitric oxide synthase/nitric oxide in vascular smooth muscle control, Perfusion, 15, 97, 10.1177/026765910001500203 Appenzeller, 2006, Cerebral vasodilatation to exogenous NO is a measure of fitness for life at altitude, Stroke, 37, 1754, 10.1161/01.STR.0000226973.97858.0b Fishman, 1975, Brain edema, N Engl J Med, 293, 706, 10.1056/NEJM197510022931407 Klatzo, 1967, Presidental address. Neuropathological aspects of brain edema, J Neuropathol Exp Neurol, 26, 1, 10.1097/00005072-196701000-00001 Na, 2004, A case of reversible postpartum cytotoxic edema in preeclampsia, J Neurol Sci, 221, 83, 10.1016/j.jns.2004.02.007 Farb, 2003, Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis, Neurology, 60, 1418, 10.1212/01.WNL.0000066683.34093.E2 Owler, 2005, Cranial venous outflow obstruction and pseudotumor Cerebri syndrome, Adv Tech Stand Neurosurg, 30, 107, 10.1007/3-211-27208-9_4 Miserocchi, 2001, Pulmonary interstitial pressure and tissue matrix structure in acute hypoxia, Am J Physiol Lung Cell Mol Physiol, 280, L881, 10.1152/ajplung.2001.280.5.L881 Houston, 1989, Incidence of acute mountain sickness at intermediate altitudes, JAMA, 261, 3551, 10.1001/jama.1989.03420240065022 Yamakawa, 2003, Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors, Circ Res, 93, 664, 10.1161/01.RES.0000093984.48643.D7 Sanchez-Elsner, 2004, A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads, J Mol Biol, 336, 9, 10.1016/j.jmb.2003.12.023 Severinghaus, 1995, Hypothesis: angiogenesis cytokines in high altitude cerebral oedema, Acta Anaesthesiol Scand Suppl, 107, 177, 10.1111/j.1399-6576.1995.tb04354.x Schoch, 2002, Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain, Brain, 125, 2549, 10.1093/brain/awf257 Schoch, 2002, Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain, Brain, 125, 2549, 10.1093/brain/awf257 Dorward, 2007, Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness, Respir Med, 101, 587, 10.1016/j.rmed.2006.06.014 Tissot van Patot, 2005, Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness, J Appl Physiol, 98, 1626, 10.1152/japplphysiol.00589.2004 Bailey, 2006, Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache, J Cereb Blood Flow Metab, 26, 99, 10.1038/sj.jcbfm.9600169 Bailey, 2004, Ascorbate, blood-brain barrier function and acute mountain sickness: a radical hypothesis, Wilderness Environ Med, 15, 231, 10.1580/1080-6032(2004)15[234:LTTE]2.0.CO;2 Bailey, 2003, Radical dioxygen: from gas to (unpaired!) electrons, Adv Exp Med Biol, 543, 201, 10.1007/978-1-4419-8997-0_15 Bailey, 2004, Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness, J Appl Physiol, 96, 1459, 10.1152/japplphysiol.00704.2003 Chan, 1984, Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals, Neurology, 34, 315, 10.1212/WNL.34.3.315 Grocott, 2007, High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine, Crit Care, 11, 203, 10.1186/cc5142